Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012

• Published in: Vaccine Vol. 32; no. 15; pp. 1768 - 1773
• Main Authors: Liu, Yu, Lin, Hualiang, Zhu, Qi, Wu, Chenggang, Zhao, Zhanjie, Zheng, Huizhen
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Ltd 26.03.2014; Elsevier; Elsevier Limited
• Subjects: Adverse Drug Reaction Reporting Systems; Adverse event following immunization; Allergies; Allergy and Immunology; Applied microbiology; Arboviral encephalitis; Arboviroses; Biological and medical sciences; Child; Child, Preschool; China; Climate change; Encephalitis; Encephalitis, Japanese - prevention & control; Female; Fever; Fundamental and applied biological sciences. Psychology; Health facilities; Human viral diseases; Humans; Immunization; Infant; Infectious diseases; Japanese encephalitis; Japanese Encephalitis Vaccines - adverse effects; Japanese Encephalitis Vaccines - therapeutic use; Live attenuated vaccine; Male; Medical sciences; Meningitis; Microbiology; Product Surveillance, Postmarketing; Safety; Tropical viral diseases; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Attenuated - adverse effects; Vaccines, Attenuated - therapeutic use; Vector-borne diseases; Viral diseases; Asia; China; Safety; Live attenuated vaccine; Adverse event following immunization; Japanese encephalitis; Nervous system diseases; Immunization; Toxicity; Vaccination; Vaccine; Pharmacovigilance; Cerebral disorder; Infection; Viral disease; Arbovirus disease; Central nervous system disease; Attenuated strain
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2013.11.107

Highlights • We reviewed adverse events of live attenuated Japanese encephalitis vaccine. • The adverse event rate was 61.24 per million doses. • Most adverse events are relatively mild, with relatively rare neurologic events.